Fed Regist. 2017 Jan 5;82(3):1210-30.
The Health Resources and Services Administration (HRSA) administers section 340B of the Public Health Service Act (PHSA), referred to as the "340B Drug Pricing Program" or the "340B Program." This final rule will apply to all drug manufacturers that are required to make their drugs available to covered entities under the 340B Program. This final rule sets forth the calculation of the 340B ceiling price and application of civil monetary penalties (CMPs).
卫生资源与服务管理局（HRSA）负责管理《公共卫生服务法》（PHSA）第340B条，即所谓的“340B药品定价计划”或“340B计划”。本最终规则将适用于所有根据340B计划被要求向合格实体提供药品的药品制造商。本最终规则规定了340B最高限价的计算方法以及民事货币处罚（CMP）的适用情况。
